Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia
Read the official source — NCT00567203This study evaluated the safety and effectiveness of PF-3463275 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleResearchers compared ALK3831, Olanzapine and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of Olanzapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ALKS 3831 and Olanzapine to find out how the approaches affected body weight in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaA Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Electrophysiology of ANAVEX3-71 in Adult Patients With Schizophrenia in a Multiple Ascending Dose Study (Part A), Followed by a Double-Blind, Randomized, Placebo-Controlled Study (Part B)
This study is no longer accepting new participants.
In MarltonA Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
Read the official source — NCT00261443Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy
This study has finished and is no longer accepting participants.
Multiple locations, including TuscaloosaA Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Read the official source — NCT00094432A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaA Study of Aripiprazole in Patients With Major Depressive Disorder
Read the official source — NCT00105196A Study of Aripiprazole in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
Read the official source — NCT00292409A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices
This study has finished and is no longer accepting participants.
Location not clearly listedA Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
Read the official source — NCT00237939This study evaluated the effectiveness of Aripiprazole for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AntwerpWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.